Bettina Rudolph
- Molecular Biology top 10%
- Cancer Research top 2%
- Immunology top 5%
- Oncology top 5%
- Cell Biology top 10%
- Co-authors
- Wen‐Chen YehAndrew WakehamTak W. MakAndrew EliaJulia M. PotterStella PelengarisTrevor D. LittlewoodDonna L. Rudolph
- Topics
- Cancer-related Molecular Pathways (4 papers)Sphingolipid Metabolism and Signaling (3 papers)HER2/EGFR in Cancer Research (3 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
Bettina Rudolph
22 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 861
- Cancer Research 707
- Immunology 576
- Oncology 456
- Cell Biology 145
Countries citing papers authored by Bettina Rudolph
This map shows the geographic impact of Bettina Rudolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Rudolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Rudolph more than expected).
Fields of papers citing papers by Bettina Rudolph
This network shows the impact of papers produced by Bettina Rudolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Rudolph. The network helps show where Bettina Rudolph may publish in the future.
Co-authorship network of co-authors of Bettina Rudolph
This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Rudolph. A scholar is included among the top collaborators of Bettina Rudolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Rudolph. Bettina Rudolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 20 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 11 | |
| 6 | 17 | |
| 7 | 37 | |
| 8 | 20 | |
| 9 | 13 | |
| 10 | 15 | |
| 11 | 68 | |
| 12 | 17 | |
| 13 | 29 | |
| 14 | 172 | |
| 15 | 419 | |
| 16 | 146 | |
| 17 | 18 | |
| 18 | 2 | |
| 19 | 0 | |
| 20 | 1 |
About Bettina Rudolph
Bettina Rudolph is a scholar working on Oncology, Immunology and Biotechnology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Sphingolipid Metabolism and Signaling (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (707 citations), Immunology (576 citations) and Oncology (456 citations). Bettina Rudolph has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Wen‐Chen Yeh, Andrew Wakeham, Tak W. Mak, Andrew Elia, Julia M. Potter, Stella Pelengaris, Trevor D. Littlewood, Donna L. Rudolph, Dorothea Rudolph and Martin Eilers. Their work appears in journals such as Genes & Development, The EMBO Journal and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.